UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

Biology of blood and marrow transplantation, 2002-01, Vol.8 (7), p.377-386

2002

Volltextzugriff (PDF)

Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD

Bone marrow transplantation (Basingstoke), 2009-12, Vol.44 (12), p.813-819

2009

Volltextzugriff (PDF)

Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease

Blood, 1999, Vol.93 (1), p.66-70

1999

Volltextzugriff (PDF)

Management of graft-versus-host disease

Blood reviews, 2000-12, Vol.14 (4), p.190-204

2000

Volltextzugriff (PDF)

Evaluation of Scales Correlated With Clinician and Patient-Perceived Symptom Change in Ocular Graft-Versus-Host Disease: Results From the Chronic GVHD Consortium

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S175-S176

2011

Volltextzugriff (PDF)

Acute bleeding after bone marrow transplantation (BMT) : Incidence and effect on survival. A quantitative analysis in 1,402 patients

Blood, 1998-02, Vol.91 (4), p.1469-1477

1998

Volltextzugriff (PDF)

61: Multi-Institutional Phase II Study of Pentostatin for the Treatment of Refractory Chronic GVHD (cGVHD) in Children: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study

Biology of blood and marrow transplantation, 2008, Vol.14 (2), p.25-25

2008

Volltextzugriff (PDF)

Etretinate Therapy for Refractory Sclerodermatous Chronic Graft-Versus-Host Disease

Blood, 1999-01, Vol.93 (1), p.66-70

1999

Volltextzugriff (PDF)

Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease

Photodermatology, photoimmunology & photomedicine, 2004-08, Vol.20 (4), p.184-190

2004

Volltextzugriff (PDF)

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial

Blood, 2006-11, Vol.108 (11), p.43-43

2006

Volltextzugriff (PDF)

Defibrotide (DF) for the Treatment of Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Analysis of Response and Survival According to Degree and Type of MOF

Blood, 2005-11, Vol.106 (11), p.399-399

2005

Volltextzugriff (PDF)

High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases

Bone marrow transplantation (Basingstoke), 2003-06, Vol.31 (12), p.1073-1080

2003

Volltextzugriff (PDF)

Association between TGF-β expression and severe GVHD in allogeneic bone marrow transplantation

Transplantation proceedings, 2001-02, Vol.33 (1-2), p.485-486

2001

Volltextzugriff (PDF)

Bone Marrow Graft Engineering by Counterflow Centrifugal Elutriation: Results of a Phase I-II Clinical Trial

Blood, 1990-03, Vol.75 (6), p.1370-1377

1990

Volltextzugriff (PDF)

Do mobilization kinetics differ among hematological malignancies (Hm) When priming and collection methods are optimized?

Experimental hematology, 2000-07, Vol.28 (7), p.94

2000

Volltextzugriff (PDF)

Using point-of-care CD34 enumeration to optimize PBSC collection conditions

Cytotherapy (Oxford, England), 2001-01, Vol.3 (1), p.11-18

2001

Volltextzugriff (PDF)

Preparative regimens in bone marrow transplantation: An analysis of outcomes in 1174 patients

International journal of radiation oncology, biology, physics, 1998, Vol.42 (1), p.194-194

1998

Volltextzugriff (PDF)

Lymphocyte Depletion of Donor Bone Marrow by Counterflow Centrifugal Elutriation: Results of a Phase I Clinical Trial

Blood, 1988-10, Vol.72 (4), p.1168-1176

1988

Volltextzugriff (PDF)

Using real time peripheral blood (PB) CD34 measurement in conjunction with a standardized priming regimen identifies differences in mobilization kinetics among patients with hematologic malignancies (HM)

Transfusion and apheresis science, 2001, Vol.24 (2), p.177-178

2001

Volltextzugriff (PDF)

Overlapping immune responses in donor lymphocyte infusion (DLI)-associated graft-vs-host disease

Biology of blood and marrow transplantation, 2004-02, Vol.10, p.54-54

2004

Volltextzugriff (PDF)

CD34 + stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine a is still required to reduce gvhd and morbidity

Transplantation proceedings, 1997-02, Vol.29 (1), p.728-732

1997

Volltextzugriff (PDF)

Allogeneic, syngeneic and autologous marrow transplantation in the acute leukemias and lymphomas--Baltimore experiences

Acta haematologica, 1987, Vol.78 Suppl 1 (1), p.175-180

1987

Volltextzugriff (PDF)

CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment

Journal of hematotherapy, 1998-04, Vol.7 (2), p.151-157

1998

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD

Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease

Management of graft-versus-host disease

Evaluation of Scales Correlated With Clinician and Patient-Perceived Symptom Change in Ocular Graft-Versus-Host Disease: Results From the Chronic GVHD Consortium

Acute bleeding after bone marrow transplantation (BMT) : Incidence and effect on survival. A quantitative analysis in 1,402 patients

61: Multi-Institutional Phase II Study of Pentostatin for the Treatment of Refractory Chronic GVHD (cGVHD) in Children: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study

Etretinate Therapy for Refractory Sclerodermatous Chronic Graft-Versus-Host Disease

Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial

Defibrotide (DF) for the Treatment of Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Analysis of Response and Survival According to Degree and Type of MOF

High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings

Association between TGF-β expression and severe GVHD in allogeneic bone marrow transplantation

Bone Marrow Graft Engineering by Counterflow Centrifugal Elutriation: Results of a Phase I-II Clinical Trial

Do mobilization kinetics differ among hematological malignancies (Hm) When priming and collection methods are optimized?

Using point-of-care CD34 enumeration to optimize PBSC collection conditions

Preparative regimens in bone marrow transplantation: An analysis of outcomes in 1174 patients

Lymphocyte Depletion of Donor Bone Marrow by Counterflow Centrifugal Elutriation: Results of a Phase I Clinical Trial

Using real time peripheral blood (PB) CD34 measurement in conjunction with a standardized priming regimen identifies differences in mobilization kinetics among patients with hematologic malignancies (HM)

Overlapping immune responses in donor lymphocyte infusion (DLI)-associated graft-vs-host disease

CD34 + stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine a is still required to reduce gvhd and morbidity

Allogeneic, syngeneic and autologous marrow transplantation in the acute leukemias and lymphomas--Baltimore experiences

CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment

Suchergebnisse filtern